The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

Many U.S. food companies are already reformulating their foods, according to Sensient Colors, one of the world’s largest ...

The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. | The FDA is introducing a ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

Ali Foley Shenk still remembers the panic when her 10-year-old son, Dean, finished a 20-ounce box of raisins in the seconds ...

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products ...

The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...

(1) The total number of outstanding shares of the Company mentioned in the relevant transparency notification amounts to 54,671,074, each share giving right to one (1) vote (being 54,671,074 voting ...

Caitlin Clark Stands Alone in WNBA History After Blistering Hot Five-Game Start GOP budget bill faces nearly 2-to-1 ...

The Federal Drug Administration is warning people about a substance that has earned the nickname "gas station heroin," called tianeptine. The product, which is typically marketed as an energy shot or ...